The fibrinolysis inhibitor alpha2-antiplasmin in the human cornea

Curr Eye Res. 2005 Dec;30(12):1097-103. doi: 10.1080/02713680500403046.

Abstract

Purpose: To determine whether the cornea contains and expresses, at the gene level, the major plasmin inhibitor alpha2-antiplasmin.

Methods: Corneal sections were immunostained for alpha2-antiplasmin. Extracts of human corneal stroma, epithelium, and endothelium were subjected to immunodot blot and Western blot analysis. Total RNA and alpha2-antiplasmin specific primers were used for RT-PCR. The cDNA was sequenced.

Results: Alpha2-antiplasmin was observed in all three corneal layers by immunolocalization and Western blots. The major alpha2-antiplasmin form observed in most extracts was the 70-kDa form. Total alpha2-antiplasmin was present at 0.119 +/- 0.014 microg/epithelium (n = 10) and 1.45 +/- 0.47 microg/stroma (n = 10). Alpha2-antiplasmin mRNA was detected in epithelial and stromal extracts and cultured human corneal stromal cells. The sequences of the PCR products were identical to that for human alpha2-antiplasmin.

Conclusions: Alpha2-antiplasmin and its mRNA are present in the cornea and may serve to regulate corneal plasmin activity.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antifibrinolytic Agents / metabolism*
  • Base Sequence
  • Blotting, Western
  • Corneal Stroma / metabolism*
  • Endothelium, Corneal / metabolism*
  • Epithelium, Corneal / metabolism*
  • Humans
  • Immunoblotting
  • Immunoenzyme Techniques
  • Middle Aged
  • Molecular Sequence Data
  • RNA, Messenger / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • alpha-2-Antiplasmin / genetics
  • alpha-2-Antiplasmin / metabolism*

Substances

  • Antifibrinolytic Agents
  • RNA, Messenger
  • alpha-2-Antiplasmin